Home » Topics » Drug design, drug delivery and technologies, BioWorld Science

Drug design, drug delivery and technologies, BioWorld Science
RSS

Somatix acquires exclusive license to gene transfer technology

July 26, 1996

Guilford obtains rights to chemotherapy drug delivery system

July 26, 1996

Ribozyme/Alza research collaboration

July 26, 1996

Techniclone International issued European patent for its Modified Antibodies Technology

July 26, 1996

Isis and ProtoGene renew drug discovery collaboration

July 26, 1996

Millennium and Wyeth-Ayerst collaborate on CNS drugs and gene therapies

July 26, 1996

Biogen and Ontogeny sign CNS drug development collaboration

July 26, 1996

Ontogen and Kanebo enter drug development collaboration

July 26, 1996

University of Michigan issued U.S. patent for gene transfer technology

July 19, 1996

CytoTherapeutics announces new biotech company

July 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...